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Age (yr) 57.6±14.7 60.0±10.9 0.436
BMI 21.2±3.1 22.3±2.9 0.552
Tumor diameter (mm) 107.6±60.9 96.8±65.6 0.539





Histology   0.467
   Borderline malignancy 26 (35.6) 2 (14.3)
   Serous 16 (21.9) 6 (42.9)
   Endometrioid 13 (17.8) 2 (14.3)
   Clear cell 17 (23.3) 3 (21.4)
   Others 1 (1.4) 1 (7.1)
FIGO stage   0.314
   I/II 45 (61.6) 4 (7.1)
   III/IV 28 (38.4) 10 (92.9)
Ascites (mL) 0.548
   >2,000  31 (42.5) 7 (50.0)
   ≤2,000  42 (57.5) 7 (50.0)
Values are presented as number (%) or mean±SD.
DVT, deep venous thrombosis. 
Table 2. Mean difference within FIGO stage 
FIGO stage No. D-dimer (µg/mL)
I/II 37 2.2±2.3






























































Table 3. Incidence of deep venous thrombosis for each level of D-dimer (DD)
Level of DD（µg/mL）
0≤DD<1.0 1.0≤DD≤3.0 3.0<DD≤10.0 10.0<DD
Total (n=87) 0/30 (0) 5/31 (16.1) 4/19 (21.1) 5/7 (71.4)
   Ovarian cancer (n=59) 0/14 (0) 3/22 (13.6) 4/18 (22.2) 5/5 (100)
   Borderline malignancy (n=28) 0/16 (0) 2/9 (22.20) 0/1 (0) 0/2 (0)
Values are presented as number (%).
Table 4. Sensitivity, specificity, PPV, and NPV of different cut-off 
D-dimer levels for diagnosis of DVT before treatment
Cut-off (µg/mL) Sensitivity Specificity PPV NPV
0.5 100 17.8  18.9 100
1.0 100 41.1 26.4 100
1.5 100 61.6 33.3 100
2.0 78.9 68.5 32.4 94.3
3.0 71.4 75.3 35.7 93.2
4.0 57.1 82.2 38.1 90.9
5.0 50.0 82.2 35.5 90.0
6.0 42.9 86.3 37.5 88.7
7.0 42.9 90.4 46.1 88.7
10.0 28.9 95.9 57.1 87.5
PPV, positive predictive value; NPV, negative predictive value; DVT, 
deep venous thrombosis. Cut-off value of D-dimer for prediction of DVT
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